Faculty mentor/PI email address
lfrankin@northwell.edu
Keywords
TEVAR, BTAI, Device Durability
Date of Presentation
5-6-2026 12:00 AM
Poster Abstract
Blunt traumatic thoracic aortic injury (BTAI) is a primary cause of mortality in blunt trauma injuries, with motor vehicle collisions representing the majority of cases.1-4 Thoracic endovascular aortic repair (TEVAR) is the standard of care for managing this vascular emergency.5 While TEVAR demonstrates favorable short-term outcomes, there is an insufficient characterization of cumulative mid- to long-term reinterventions and device-related complications in BTAI patients.
We conducted a meta-analysis/systematic review of studies reporting outcomes after TEVAR for BTAI in patients ≥45 years. This review was conceptualized as a comparator to the previously reviewed outcomes in younger patients (< 45 years) performed by Frankini et al. (2026)6, and aims to characterize mid- to long-term age-stratified durability, reintervention burden, and device-related complications after TEVAR for BTAI in older patients. Of the 415 studies initially screened, 4 studieswere selected for quantitative meta-analysis.7-10 Metrics on reintervention and device-related complications were collected in addition to adverse events. Random-effects single-arm meta-analyses of proportions were performed on all collected outcomes. Findings show 162 analyzable BTAI patients were treated with TEVAR. Total reintervention was 5.53% (95% CI, 1.79%–15.82%; 4 studies, n=162; I²=50.0%), with device-related complications being 5.26% (1 study, n=38).
Overall, TEVAR for BTAI demonstrates favorable mid- to long-term durability with low rates of reintervention and infrequent device-related adverse events in patients aged ≥45 years. Initial comparison between this study’s cohort and Frankini et al. (2026)6 showed a higher pooled reintervention rate and higher all-cause mortality in BTAI patients aged ≥45 years who received TEVAR.
Disciplines
Cardiovascular Diseases | Medicine and Health Sciences | Surgery
Included in
Mid- to Long-Term Durability of Thoracic Endovascular Aortic Repair for Blunt Thoracic Aortic Injury: Outcomes in ≥ 45 Comparator Cohort
Blunt traumatic thoracic aortic injury (BTAI) is a primary cause of mortality in blunt trauma injuries, with motor vehicle collisions representing the majority of cases.1-4 Thoracic endovascular aortic repair (TEVAR) is the standard of care for managing this vascular emergency.5 While TEVAR demonstrates favorable short-term outcomes, there is an insufficient characterization of cumulative mid- to long-term reinterventions and device-related complications in BTAI patients.
We conducted a meta-analysis/systematic review of studies reporting outcomes after TEVAR for BTAI in patients ≥45 years. This review was conceptualized as a comparator to the previously reviewed outcomes in younger patients (< 45 years) performed by Frankini et al. (2026)6, and aims to characterize mid- to long-term age-stratified durability, reintervention burden, and device-related complications after TEVAR for BTAI in older patients. Of the 415 studies initially screened, 4 studieswere selected for quantitative meta-analysis.7-10 Metrics on reintervention and device-related complications were collected in addition to adverse events. Random-effects single-arm meta-analyses of proportions were performed on all collected outcomes. Findings show 162 analyzable BTAI patients were treated with TEVAR. Total reintervention was 5.53% (95% CI, 1.79%–15.82%; 4 studies, n=162; I²=50.0%), with device-related complications being 5.26% (1 study, n=38).
Overall, TEVAR for BTAI demonstrates favorable mid- to long-term durability with low rates of reintervention and infrequent device-related adverse events in patients aged ≥45 years. Initial comparison between this study’s cohort and Frankini et al. (2026)6 showed a higher pooled reintervention rate and higher all-cause mortality in BTAI patients aged ≥45 years who received TEVAR.